Biofrontera BFRI Stock
Biofrontera Price Chart
Biofrontera BFRI Financial and Trading Overview
| Biofrontera stock price | 0.84 USD |
| Previous Close | 0.43 USD |
| Open | 0.43 USD |
| Bid | 0 USD x 4000 |
| Ask | 0 USD x 1000 |
| Day's Range | 0.42 - 0.43 USD |
| 52 Week Range | 0.37 - 2.25 USD |
| Volume | 55.38K USD |
| Avg. Volume | 72.41K USD |
| Market Cap | 11.35M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.22 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.5 USD |
BFRI Valuation Measures
| Enterprise Value | -8544924 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.4655173 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.41029343 |
| Price/Book (mrq) | 0.677831 |
| Enterprise Value/Revenue | -0.309 |
| Enterprise Value/EBITDA | 0.38 |
Trading Information
Biofrontera Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -79.46% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.25 USD |
| 52 Week Low | 0.37 USD |
| 50-Day Moving Average | 0.53 USD |
| 200-Day Moving Average | 0.83 USD |
BFRI Share Statistics
| Avg. Volume (3 month) | 72.41K USD |
| Avg. Daily Volume (10-Days) | 51.02K USD |
| Shares Outstanding | 26.7M |
| Float | 15.21M |
| Short Ratio | 1.83 |
| % Held by Insiders | 42.39% |
| % Held by Institutions | 7.39% |
| Shares Short | 215.61K |
| Short % of Float | 1.39% |
| Short % of Shares Outstanding | 0.80% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -49.46% |
| Operating Margin (ttm) | -83.073% |
| Gross Margin | 47.08% |
| EBITDA Margin | -81.21% |
Management Effectiveness
| Return on Assets (ttm) | -31.50% |
| Return on Equity (ttm) | -80.070% |
Income Statement
| Revenue (ttm) | 27.66M USD |
| Revenue Per Share (ttm) | 1.18 USD |
| Quarterly Revenue Growth (yoy) | -10.40% |
| Gross Profit (ttm) | 13.49M USD |
| EBITDA | -22460000 USD |
| Net Income Avi to Common (ttm) | -13679000 USD |
| Diluted EPS (ttm) | -0.64 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 21.1M USD |
| Total Cash Per Share (mrq) | 0.79 USD |
| Total Debt (mrq) | 1.21M USD |
| Total Debt/Equity (mrq) | 7.22 USD |
| Current Ratio (mrq) | 1.82 |
| Book Value Per Share (mrq) | 0.627 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17776000 USD |
| Levered Free Cash Flow (ttm) | -55375 USD |
Profile of Biofrontera
| Country | United States |
| State | MA |
| City | Woburn |
| Address | 120 Presidential Way |
| ZIP | 01801 |
| Phone | 781-245-1325 |
| Website | https://www.biofrontera-us.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 81 |
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription drug for the treatment of impetigo. The company was founded in 1997 and is headquartered in Woburn, Massachusetts.
Q&A For Biofrontera Stock
What is a current BFRI stock price?
Biofrontera BFRI stock price today per share is 0.84 USD.
How to purchase Biofrontera stock?
You can buy BFRI shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biofrontera?
The stock symbol or ticker of Biofrontera is BFRI.
Which industry does the Biofrontera company belong to?
The Biofrontera industry is Drug Manufacturers-Specialty & Generic.
How many shares does Biofrontera have in circulation?
The max supply of Biofrontera shares is 8.87M.
What is Biofrontera Price to Earnings Ratio (PE Ratio)?
Biofrontera PE Ratio is now.
What was Biofrontera earnings per share over the trailing 12 months (TTM)?
Biofrontera EPS is -3.22 USD over the trailing 12 months.
Which sector does the Biofrontera company belong to?
The Biofrontera sector is Healthcare.
Biofrontera BFRI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}